WILMINGTON, DE ─ DuPont has entered into a definitive agreement for the acquisition of Danisco, a global enzyme and specialty food ingredients company, for $5.8 billion in cash and assumption of $500 million of Danisco net debt. Upon closing, this transaction would establish DuPont as a clear leader in industrial biotechnology with science-intensive innovations that address global challenges in food production and reduced fossil fuel consumption.
“This transaction is a perfect strategic fit with our growth opportunities and will help us solve global challenges presented by dramatic population growth in the decades to come, specifically related to food and energy. In addition, biotechnology and specialty food ingredients have the potential to change the landscape of industries, such as substituting renewable materials for fossil fuel processes and addressing food needs in developing economies, that will generate more sustainable solutions and create growth for the company,” said DuPont Chair and CEO Ellen Kullman.
The acquisition is expected to be financed with about $3 billion in existing cash and the remainder in debt. The transaction is expected to close early in the second quarter and be cash and earnings accretive in 2012, the first full year of the combined entity.
DuPont has set its 2011 earnings per share outlook at a range of $3.30 to $3.60 per share. The anticipated impact of this transaction would reduce that outlook by $.30 to $.45 per share on a reported basis.
Danisco has specialty food ingredients, including enablers, cultures and sweeteners, that generate about 65 percent of total sales. Genencor, its enzymes division, represents 35 percent of total sales. Danisco has nearly 7,000 employees globally with operations in 23 countries. Danisco and DuPont are already joint-venture partners in the development of cellulosic ethanol technology.
DuPont to Acquire Danisco for $6.3 Billion
January 16, 2011